Clinical Trial Update: Rituximab for Pulmonary Sarcoidosis [Phase 2]

View source ↗

Summary

Phase 2 trial investigating rituximab for pulmonary sarcoidosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoidosis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: University of Cincinnati | Conditions: Sarcoidosis | Phase 2 | Status: COMPLETED